Antisens modulation of integrin alpha4 expression

Details for Australian Patent Application No. 2005327506 (hide)

Owner Antisense Therapeutics Ltd

Inventors Karras, James G.; Tachas, George; Crosby, Jeffrey R.; Gregory, Susan; Dobie, Kenneth W.; Bennett, C. Frank

Agent FB Rice

Pub. Number AU-B-2005327506

PCT Pub. Number WO2006/086821

Priority 60/648,820 31.01.05 US; 60/620,792 20.10.04 US

Filing date 20 October 2005

Wipo publication date 24 August 2006

Acceptance publication date 8 July 2010

International Classifications

A61K 31/711 (2006.01) - Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

Event Publications

19 April 2007 PCT application entered the National Phase

  PCT publication WO2006/086821 Priority application(s): WO2006/086821

8 July 2010 Application Accepted

  Published as AU-B-2005327506

12 August 2010 Amendment Made

  The nature of the amendment is: Amend the invention title to read Antisense modulation of integrin alpha4 expression 2006

4 November 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005327507-A molecule and chimeric molecules thereof

2005327500-Intervertebral implant